<DOC>
	<DOCNO>NCT00356798</DOCNO>
	<brief_summary>Based pre-clinical trial data principle GCP , objective phase I clinical trial evaluate safety immunogenicity Pan-flu vaccine , inactivated whole virion H5N1 vaccine aluminium hydroxide adjuvant .</brief_summary>
	<brief_title>Randomized , Double Blinded , Placebo Control Clinical Trial Pandemic Influenza Inactive Vaccine Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males female , age 18 60 year old ; Able provide proof identity satisfaction study clinician complete enrollment process ; Able willing complete inform consent process . Woman breastfeed plan become pregnant follow 210 day study participation ; Persons engage follow occupation : culturist , slaughter , sale forwarder avian ; Subject medical history following : allergic history , allergic ingredient vaccine , egg , egg protein , etc ; Serious adverse reaction vaccine anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain ; Autoimmune disease immunodeficiency ; Asthma unstable require emergent care , urgent care , hospitalization intubation past two year require use oral intravenous corticosteroid ; Diabetes mellitus ( type I II ) , exception gestational diabetes ; History thyroidectomy thyroid disease require medication within past 12 month ; Serious angioedema episode within previous 3 year require medication previous two year ; Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draw ; Malignancy active treat malignancy reasonable assurance sustain cure malignancy likely recur period study ; Seizure disorder 1 ) febrile seizure age two , 2 ) seizure secondary alcohol withdrawal 3 year ago , 3 ) singular seizure require treatment within last 3 year ; Asplenia , functional asplenia condition result absence removal spleen ; GuillainBarre Syndrome ( GBS ) ; Abnormal result laboratory test : Biochemistry assaying : Alanine Aminotransferase /Serum Glutamate Pyruvate Transaminase ( ALT ) , Total Bilirubine Tbil ( TBIL ) , Direct Bilirubine Tbil ( DBIL ) , Blood Urea Nitrogen ( BUN ) Creatinine ( Cr ) . Routine blood assaying , routine urine assay . HBsAg positive ; Pregnancy test positive female ; Subject receive follow substance : Immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) . Blood product within 3 month prior initial study vaccine administration . Other study drug within 30 day prior initial study vaccine administration . Live attenuate vaccine within 30 day prior initial study vaccine administration . Medically indicated subunit kill vaccine , e.g . pneumococcal , allergy treatment antigen injection , within 14 day study vaccine administration . Current antiTB prophylaxis therapy . Fever vaccination , axillary temperature 37.0 centigrades . Psychiatric condition precludes compliance protocol ; past present psychosis ; past present bipolar disorder require therapy well control medication past two year ; disorder require lithium ; suicidal ideation occur within five year prior enrollment . Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>pandemic</keyword>
	<keyword>influenza</keyword>
	<keyword>H5N1</keyword>
	<keyword>vaccine</keyword>
</DOC>